Inventor
REI OKAMOTO
Inventor
JP
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes16%
C07KPeptides13%
Y02ATechnologies for adaptation to climate change10%
C07BGeneral methods of organic chemistry3%
PatentTitleYear
12,522,603Inhibitors of gas for treating autoinflammatory diseases and cancer metastasis202612,473,331Macrocyclic compounds as proteasome inhibitors202512,091,410Heterocyclic compound202412,071,434Heterocyclic compound202411,834,515Macrocyclic compounds as proteasome inhibitors202311,732,005Peptidomimetic proteasome inhibitors202311,414,422Substituted pyrido[4,3-b]indoles and azepino[4,5-b]indoles as inhibitors of cGAS202211,203,613Peptidomimetic proteasome inhibitors202111,197,858Substituted amines for treating cardiac diseases2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to TRI INST THERAPEUTICS DISCOVERY INST (4)· patent assignee history
2021–2025Patents assigned to UNIV CORNELL (4)· patent assignee history
2021–2026Based in JP· patent location history
2022–2026Patents assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (2)· patent assignee history
2022–2026Patents assigned to UNIV ROCKEFELLER (2)· patent assignee history
2024Patents assigned to TAKEDA PHARMACEUTICALS CO (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TRI INST THERAPEUTICS DISCOVERY INST | 4 | 2021–2025 |
| UNIV CORNELL | 4 | 2021–2025 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 2 | 2022–2026 |
| TAKEDA PHARMACEUTICALS CO | 2 | 2024 |
| UNIV ROCKEFELLER | 2 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 9 | 2021–2026 |